Figure 2.

(a) Traditional de novo drug discovery takes up to 17 years from drug identification to market. (b) In-vitro and in-vivo screening, validation, lead optimisation, and efficacy studies require significantly lesser time thus resulting in significant time overall time saved and reduced overall cost.